Literature DB >> 27345961

Sarcolipin knockout mice fed a high-fat diet exhibit altered indices of adipose tissue inflammation and remodeling.

Rebecca E K MacPherson1, Daniel Gamu2, Scott Frendo-Cumbo1, Laura Castellani1, Frenk Kwon2, A Russell Tupling2, David C Wright1.   

Abstract

OBJECTIVE: To investigate indices of adipose tissue inflammation and remodeling in high-fat diet (HFD) sarcolipin-knockout (SLN(-) (/-) ) mice. SLN regulates muscle-based nonshivering thermogenesis and is up-regulated with HFD. SLN(-) (/-) mice develop greater diet-induced obesity and glucose intolerance. This is accompanied by increases in circulating catecholamines and fatty acids. Catecholamines and fatty acids play a role in the pathology of adipose tissue inflammation.
METHODS: Male mice (wild type and SLN(-) (/-) ) were fed a HFD (42% kcal from fat) for 8 weeks.
RESULTS: SLN(-) (/-) mice displayed greater obesity and glucose intolerance. This was accompanied by higher circulating epinephrine and nonesterified fatty acids. Epididymal but not inguinal subcutaneous adipose tissue from SLN(-) (/-) mice displayed higher interleukin-6, suppressor of cytokine signaling 3, interleukin-1β, and tumor necrosis factor-α mRNA expression, and this was associated with increased markers of macrophage infiltration (F4/80 expression and crown-like structures) and M1 polarization (higher CD11c expression and CD11c/MGL1). Interestingly, this occurred despite SLN(-) (/-) mice having smaller adipocytes.
CONCLUSIONS: In conditions of nutrient excess, SLN(-) (/-) mice display depot-specific increases in indices of adipose tissue inflammation and remodeling. This could be a compensatory response to reductions in muscle-based thermogenesis.
© 2016 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27345961     DOI: 10.1002/oby.21521

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  8 in total

1.  Estradiol does not directly regulate adipose lipolysis.

Authors:  Tara L MacDonald; Rebecca MacPherson; Laura Castellani; Daniel Cervone; Eoin Anderson; David C Wright; David J Dyck
Journal:  Adipocyte       Date:  2017-01-27       Impact factor: 4.534

Review 2.  Creatine metabolism: energy homeostasis, immunity and cancer biology.

Authors:  Lawrence Kazak; Paul Cohen
Journal:  Nat Rev Endocrinol       Date:  2020-06-03       Impact factor: 43.330

Review 3.  Uncoupling of sarcoendoplasmic reticulum calcium ATPase pump activity by sarcolipin as the basis for muscle non-shivering thermogenesis.

Authors:  Naresh C Bal; Muthu Periasamy
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-01-13       Impact factor: 6.237

4.  Beneficial effects of combined resveratrol and metformin therapy in treating diet-induced insulin resistance.

Authors:  Scott Frendo-Cumbo; Rebecca E K MacPherson; David C Wright
Journal:  Physiol Rep       Date:  2016-08

Review 5.  Metabolic Regulation of Adipose Tissue Macrophage Function in Obesity and Diabetes.

Authors:  Mahesh Appari; Keith M Channon; Eileen McNeill
Journal:  Antioxid Redox Signal       Date:  2017-10-13       Impact factor: 8.401

Review 6.  Creatine in T Cell Antitumor Immunity and Cancer Immunotherapy.

Authors:  Bo Li; Lili Yang
Journal:  Nutrients       Date:  2021-05-13       Impact factor: 5.717

7.  Sarcolipin Signaling Promotes Mitochondrial Biogenesis and Oxidative Metabolism in Skeletal Muscle.

Authors:  Santosh K Maurya; Jose L Herrera; Sanjaya K Sahoo; Felipe C G Reis; Rick B Vega; Daniel P Kelly; Muthu Periasamy
Journal:  Cell Rep       Date:  2018-09-11       Impact factor: 9.423

8.  A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided.

Authors:  Rebecca L Paszkiewicz; Richard N Bergman; Roberta S Santos; Aaron P Frank; Orison O Woolcott; Malini S Iyer; Darko Stefanovski; Deborah J Clegg; Morvarid Kabir
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.